|Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial|
WJ Marks Jr, RT Bartus, J Siffert, CS Davis, A Lozano, N Boulis, J Vitek, ...
The Lancet Neurology 9 (12), 1164-1172, 2010
|Intracerebral hemorrhage-induced neuronal death|
C Gong, N Boulis, J Qian, DE Turner, JT Hoff, RF Keep
Neurosurgery 48 (4), 875-883, 2001
|Use of factor IX complex in warfarin-related intracranial hemorrhage|
NM Boulis, MP Bobek, A Schmaier, JT Hoff
Neurosurgery 45 (5), 1113-1119, 1999
|Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients|
JD Glass, NM Boulis, K Johe, SB Rutkove, T Federici, M Polak, C Kelly, ...
Stem cells 30 (6), 1144-1151, 2012
|Progress in gene therapy for neurological disorders|
M Simonato, J Bennett, NM Boulis, MG Castro, DJ Fink, WF Goins, ...
Nature Reviews Neurology 9 (5), 277-291, 2013
|Gene delivery of neurturin to putamen and substantia nigra in P arkinson disease: A double‐blind, randomized, controlled trial|
C Warren Olanow, RT Bartus, TL Baumann, S Factor, N Boulis, M Stacy, ...
Annals of neurology 78 (2), 248-257, 2015
|Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes|
EL Feldman, NM Boulis, J Hur, K Johe, SB Rutkove, T Federici, M Polak, ...
Annals of neurology 75 (3), 363-373, 2014
|Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients|
RT Bartus, TL Baumann, J Siffert, CD Herzog, R Alterman, N Boulis, ...
Neurology 80 (18), 1698-1701, 2013
|Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery|
BR Snyder, SJ Gray, ET Quach, JW Huang, CH Leung, RJ Samulski, ...
Human gene therapy 22 (9), 1129-1135, 2011
|Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs|
T Federici, JS Taub, GR Baum, SJ Gray, JC Grieger, KA Matthews, ...
Gene therapy 19 (8), 852-859, 2012
|Human neural stem cell transplantation in ALS: initial results from a phase I trial|
L Mazzini, M Gelati, DC Profico, G Sgaravizzi, MP Pensi, G Muzi, ...
Journal of translational medicine 13 (1), 1-16, 2015
|Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes|
J Riley, T Federici, M Polak, C Kelly, J Glass, B Raore, J Taub, V Kesner, ...
Neurosurgery 71 (2), 405-416, 2012
|Psychophysical study of numbers|
JC Baird, E Noma
Psychological Research 37 (4), 281-297, 1975
|Urinary retention following routine neurosurgical spine procedures|
NM Boulis, FS Mian, D Rodriguez, E Cho, JT Hoff
Surgical neurology 55 (1), 23-27, 2001
|Surgery for movement disorders|
AR Rezai, AG Machado, M Deogaonkar, H Azmi, C Kubu, NM Boulis
Neurosurgery 62 (suppl_2), SHC809-SHC839, 2008
|A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting|
JK Liu, Q Teng, M Garrity-Moses, T Federici, D Tanase, MJ Imperiale, ...
Neurobiology of disease 19 (3), 407-418, 2005
|Perioperative events during deep brain stimulation: the experience at Cleveland clinic|
R Khatib, Z Ebrahim, A Rezai, JP Cata, NM Boulis, DJ Doyle, T Schurigyn, ...
Journal of neurosurgical anesthesiology 20 (1), 36-40, 2008
|Transplantation of spinal cord–derived neural stem cells for ALS: Analysis of phase 1 and 2 trials|
JD Glass, VS Hertzberg, NM Boulis, J Riley, T Federici, M Polak, ...
Neurology 87 (4), 392-400, 2016
|Gene therapy for neurodegenerative diseases|
DM O’Connor, NM Boulis
Trends in molecular medicine 21 (8), 504-512, 2015
|A novel endoscopic technique in treating single nerve entrapment syndromes with special attention to ulnar nerve transposition and tarsal tunnel release: clinical application|
KG Krishnan, T Pinzer, G Schackert
Operative Neurosurgery 59 (suppl_1), ONS-89-ONS-100, 2006